Quintiles
From Wikipedia, the free encyclopedia
 |
This article appears to be written like an advertisement. Please help improve it by rewriting promotional content from a neutral point of view and removing any inappropriate external links. (June 2011) |
 |
This article appears to contain a large number of buzzwords. Specific concerns can be found on the talk page. Please help improve this article if you can. (July 2011) |
| Type | Private |
|---|---|
| Industry | Contract Research Organization Pharmaceutical Service Consulting |
| Founded | 1982 |
| Headquarters | Durham, North Carolina, USA |
| Key people | Dennis Gillings, Chairman & CEO John Ratliff President & COO |
| Products | Support services for pharmaceutical, biotech and medical companies and individuals |
| Revenue |  US$ Approximately $3.0 billion |
| Employees | ~ 20,000+ (2011) |
| Website | http://www.quintiles.com/ |
Quintiles Transnational is a pharmaceutical services company offering clinical, commercial, consulting and capital services. The Quintiles network consists of more than 20,000 employees in 60 countries.[citation needed]
Quintiles manages clinical trials on behalf of pharmaceutical customers, and provides the following services:
- Management of clinical trials, data, projects and providing laboratory services
- Providing customers with sales force, product and brand solutions[clarification needed]
- Providing data-driven recommendations to help customers achieve success[clarification needed]
- Creating strategic partnerships through financing and operational solutions[clarification needed]
Quintiles helped develop or commercialize all of 2009's top 50 best selling drugs or compounds and nearly 90% of all breakthrough products released on the market between 1996 and 2008.[1][not in citation given]
[edit] History
Quintiles was founded in 1982 by Dennis Gillings, Ph.D., CBE, then a professor of biostatistics at the University of North Carolina, Chapel Hill.[2]
Key Dates:
- 1974: Dennis Gillings signs first contract to provide statistical and data management consulting for pharmaceutical clients.
- 1982: Quintiles, Inc., is incorporated in North Carolina.
- 1990: Quintiles Pacific Inc. and Quintiles Ireland Ltd. established
- 1991: Quintiles GMBH established in Germany; Quintiles Laboratories Ltd. established in Atlanta, Georgia
- 1996: Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO[3]
- 1997: Quintiles goes public, completing successful secondary stock offering.
- 1998: Quintiles is the first company in industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
- 1999: Company joins the S&P 500 Index.
- 2003: Board of Directors agrees to merge with Pharma Services Holdings Inc; Quintiles becomes a private company.
- 2009: Quintiles opens new corporate headquarters in Durham, North Carolina
- 2010: Quintiles opens new European headquarters in the UK and establishes operations in East Africa.
- 2011: Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York
[edit] References
- ^ EvaluatePharma, Top 100 Drugs 2009, April 14, 2010
- ^ "Money, Math and Medicine". Forbes Magazine. November 22, 2010. http://www.forbes.com/forbes/2010/1122/private-companies-10-quintiles-dennis-gillings-money-medicine.html. Retrieved April 14, 2011.
- ^ "High-Flying Quintiles to Buy Innovex in $747.5 Million Deal". New York Times. October 8, 1996. http://select.nytimes.com/gst/abstract.html?res=FB0C11FE3D5A0C7B8CDDA90994DE494D81. Retrieved April 14, 2011.
